Zydus Cadila gets tentative USFDA nod to market lung cancer treatment drug

Zydus Cadila gets tentative USFDA nod to market lung cancer treatment drug The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Osimertinib tablets in the strengths of 40 mg and 80 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing. https://ift.tt/eA8V8J